Treatment practices and costs among patients with psoriatic arthritis: A Japanese hospital claims database analysis

References

• Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28(3):554–9.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14–ii7.
   PubMed Web of Science ®Google Scholar
• Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H, et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open. 2015;5(1):e006450.
   PubMed Web of Science ®Google Scholar
• Ohara Y, Kishimoto M, Takizawa N, Yoshida K, Okada M, Eto H, et al. Prevalence and clinical characteristics of psoriatic arthritis in Japan. J Rheumatol. 2015;42(8):1439–42.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Ohtsuki M, Sano S, Igarashi A, Morita A, Okuyama R, et al. Epidemiological analysis of psoriatic arthritis patients in Japan. J Dermatol. 2016;43(10):1193–6.
   PubMed Web of Science ®Google Scholar
• Tanaka YP. arthritis in Japan: difference in clinical features and approach to precision medicine. Clin Exp Rheumatol. 2016;34(4 Suppl 98):49–52.
   PubMed Web of Science ®Google Scholar
• Yang Q, Qu L, Tian H, Hu Y, Peng J, Yu X, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25(12):1409–14.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–35.
   PubMed Web of Science ®Google Scholar
• Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med. 2016;374(26):2563–74.
   PubMed Web of Science ®Google Scholar
• Ohtsuki M, Terui T, Ozawa A, Morita A, Sano S, Takahashi H, et al. Japanese guidance for use of biologics for psoriasis (the 2013 version). J Dermatol. 2013;40(9):683–95.
   PubMed Web of Science ®Google Scholar
• Saeki H, Terui T, Morita A, Sano S, Imafuku S, Asahina A, et al. Japanese guidance for use of biologics for psoriasis (the 2019 version). J Dermatol. 2020;47(3):201–22.
   PubMed Web of Science ®Google Scholar
• Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510.
   PubMed Web of Science ®Google Scholar
• Sruamsiri R, Iwasaki K, Tang W, Mahlich J. Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database. BMC Dermatol. 2018;18(1):5.
   PubMedGoogle Scholar
• Tomita T, Sato M, Esterberg E, Parikh RC, Hagimori K, Nakajo K. Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: a hospital claims database analysis. Mod Rheumatol 2020;2020:1–11.
   Google Scholar
• Akazawa M, Database, research and regulation in Japan. Presented at the ISPOR Asia Pacific 2018, Tokyo, Japan. 2018.
   Google Scholar
• Medical.Data.Vision. Introducing MDV Database. 2020. Available from: https://www.mdv.co.jp/mdv_database/english/ [last accessed 28 Feb 2020].
   Google Scholar
• Sato M, Ye W, Sugihara T, Isaka Y. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database. BMC Musculoskelet Disord. 2016;17(1):489.
   PubMed Web of Science ®Google Scholar
• Fuji T, Akagi M, Abe Y, Oda E, Matsubayashi D, Ota K, et al. Incidence of venous thromboembolism and bleeding events in patients with lower extremity orthopedic surgery: a retrospective analysis of a Japanese healthcare database. J Orthop Surg Res. 2017;12(1):55.
   PubMedGoogle Scholar
• Tanaka K, Hamada K, Nakayama T, Matsuda S, Atsumi A, Shimura T, et al. Risk for cardiovascular disease in Japanese patients with rheumatoid arthritis: a large-scale epidemiological study using a healthcare database. Springerplus. 2016;5(1):1111.
   PubMedGoogle Scholar
• Wang F, Mishina S, Takai S, Le TK, Ochi K, Funato K, et al. Systemic treatment patterns with advanced or recurrent non-small cell lung cancer in Japan: a retrospective hospital administrative database study. Clin Ther. 2017;39(6):1146–60.
   PubMed Web of Science ®Google Scholar
• Walsh JA, Adejoro O, Chastek B, Palmer JB, Hur P. Treatment patterns among patients with psoriatic arthritis treated with a biologic in the United States: descriptive analyses from an administrative claims database. J Manag Care Spec Pharm. 2018;24(7):623–31.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234–40.
   PubMed Web of Science ®Google Scholar
• Walsh JA, Adejoro O, Chastek B, Park Y. Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database. J Comp Eff Res. 2018;7(4):369–80.
   PubMed Web of Science ®Google Scholar
• Japan’s consumer price index annual report. 2018. Available from: https://www.stat.go.jp/english/data/cpi/index.html [last accessed 4 Dec 2019].
   Google Scholar
• Pound Sterling Live. The U.S. Dollar to Japanese Yen Historical Exchange Rates Conversion Page for 2018. 2019. Available from: https://www.poundsterlinglive.com/best-exchange-rates/best-us-dollar-to-japanese-yen-history-2018 [last accessed 30 Mar 2020].
   Google Scholar
• Shah K, Paris M, Mellars L, Changolkar A, Mease PJ. Real-world burden of comorbidities in US patients with psoriatic arthritis. RMD Open. 2017;3(2):e000588.
   PubMed Web of Science ®Google Scholar
• Merola JF, Peterson S, Dennis N, Chakravarty SD, Mesana L, Lin I, et al. Retrospective study examining health care utilization and costs for patients with psoriasis and psoriatic arthritis in the US. ISPOR 2020. Orlando, FL, USA.
   Google Scholar
• Kishimoto M, Komine M, Kamiya K, Sugai J, Mieno M, Ohtsuki M. Drug survival of biologic agents for psoriatic patients in a real-world setting in Japan. J Dermatol. 2020;47(1):33–40.
   PubMed Web of Science ®Google Scholar
• Lee MP, Lii J, Jin Y, Desai RJ, Solomon DH, Merola JF, et al. Patterns of systemic treatment for psoriatic arthritis in the US: 2004–2015. Arthritis Care Res. 2018;70(5):791–6.
   Web of Science ®Google Scholar
• Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, et al. Special article: 2018 American College of rheumatology/national psoriasis foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):5–32.
   PubMed Web of Science ®Google Scholar
• Reddy SM, Crean S, Martin AL, Burns MD, Palmer JB. Real-world effectiveness of anti-TNF switching in psoriatic arthritis: a systematic review of the literature. Clin Rheumatol. 2016;35(12):2955–66.
   PubMed Web of Science ®Google Scholar